Biotium has unveiled its innovative MiniMab™ single-domain antibody (SdAb) series, engineered specifically for stochastic optical reconstruction microscopy (STORM) applications in neuroscience research. The California-based life science reagent developer has introduced three high-performance recombinant alpaca VHH antibodies targeting critical neural proteins: glial fibrillary acidic protein (GFAP), synaptotagmin 1 (SYT1), and vesicular glutamate transporter 1 (VGLUT1).

Reduce the validation burden for your laboratory and reliably enrich plasma cells with the EasySep™ Human Bone Marrow CD138 Positive Selection Kit — STEMCELL’s newest CE IVDR-compliant in vitro diagnostic device — designed specifically for hematopoietic cell enrichment..

Cancer diagnostics laboratories have gained a powerful new tool in the fight against genomic complexity. Revvity has unveiled its first FDA-compliant IVD Mimix reference standards, engineered to revolutionise quality control in next-generation sequencing and droplet digital PCR workflows for oncology applications.

BioSkryb Genomics and Tecan Group have unveiled an integrated single-cell multiomics workflow that promises to transform highthroughput cellular analysis. The partnership combines BioSkryb’s ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit in 384-well format with Tecan’s Uno Single Cell Dispenser™, enabling parallel analysis of hundreds to thousands of individual cells whilst significantly reducing manual intervention.

Swiss proteomics leader Biognosys has launched two major software updates that promise to revolutionise mass spectrometry-based protein analysis, with particular advances in immunopeptidomics research critical for therapeutic development.